FCGR3A and COVID-19: Two studies showed by flow cytometry that the numbers of CD16+ monocytes were lower in the peripheral blood of individuals with severe COVID-19 compared to mild and control groups, and that within this population, there was decreased HLA-DR expression (21, 41).